Literature DB >> 10607305

Glycosylation of immunoglobulin A influences its receptor binding.

C Basset1, V Devauchelle, V Durand, C Jamin, Y L Pennec, P Youinou, M Dueymes.   

Abstract

Immunoglobulin A (IgA), which is heavily glycosylated, interacts with a variety of receptors, e.g. the asialoglycoprotein receptor (ASGP-R), which binds terminal galactose residues, and the Fcalpha receptor (FcalphaRI). It has thus been proposed that elevated serum levels of IgA in primary Sjögren's syndrome (pSS) are caused by its defective clearance. To test this hypothesis, we developed a method (based on sialyl transferases eluted from a hepatoma cell line) to increase the amount of sialic acid (SA) on IgA, and used a battery of IgA1- and IgA2-specific glycosidases to reduce this amount. Binding of IgA1 and IgA2 to ASGP-R and FcalphaRI was found to be sugar dependent because oversialylated IgA bound less than native or desialylated IgA. However, individual sugars did not play a direct role in this binding. Given that IgA are oversialylated in pSS, defective clearance of IgA may indeed be ascribed to an excess of SA in IgA1 and IgA2.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10607305     DOI: 10.1046/j.1365-3083.1999.00628.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  20 in total

Review 1.  Progress in molecular and genetic studies of IgA nephropathy.

Authors:  J Novak; B A Julian; M Tomana; J Mesteck
Journal:  J Clin Immunol       Date:  2001-09       Impact factor: 8.317

2.  IgA and IgA-specific receptors in human disease: structural and functional insights into pathogenesis and therapeutic potential.

Authors:  Michelle M Gomes; Andrew B Herr
Journal:  Springer Semin Immunopathol       Date:  2006-10-17

3.  Spec-seq unveils transcriptional subpopulations of antibody-secreting cells following influenza vaccination.

Authors:  Karlynn E Neu; Jenna J Guthmiller; Min Huang; Jennifer La; Marcos C Vieira; Kangchon Kim; Nai-Ying Zheng; Mario Cortese; Micah E Tepora; Natalie J Hamel; Karla Thatcher Rojas; Carole Henry; Dustin Shaw; Charles L Dulberger; Bali Pulendran; Sarah Cobey; Aly A Khan; Patrick C Wilson
Journal:  J Clin Invest       Date:  2018-11-19       Impact factor: 14.808

4.  Differences in N-glycan structures found on recombinant IgA1 and IgA2 produced in murine myeloma and CHO cell lines.

Authors:  Esther M Yoo; Li J Yu; Letitia A Wims; David Goldberg; Sherie L Morrison
Journal:  MAbs       Date:  2010-05-17       Impact factor: 5.857

Review 5.  Mass spectrometry for the identification and analysis of highly complex glycosylation of therapeutic or pathogenic proteins.

Authors:  Yukako Ohyama; Kazuki Nakajima; Matthew B Renfrow; Jan Novak; Kazuo Takahashi
Journal:  Expert Rev Proteomics       Date:  2020-05-28       Impact factor: 3.940

Review 6.  Glycans in the immune system and The Altered Glycan Theory of Autoimmunity: a critical review.

Authors:  Emanual Maverakis; Kyoungmi Kim; Michiko Shimoda; M Eric Gershwin; Forum Patel; Reason Wilken; Siba Raychaudhuri; L Renee Ruhaak; Carlito B Lebrilla
Journal:  J Autoimmun       Date:  2015-01-09       Impact factor: 7.094

Review 7.  Sweet Rules: Linking Glycosylation to Antibody Function.

Authors:  Falk Nimmerjahn; Anja Werner
Journal:  Exp Suppl       Date:  2021

8.  Immunoglobulin A Glycosylation and Its Role in Disease.

Authors:  Alyssa L Hansen; Colin Reily; Jan Novak; Matthew B Renfrow
Journal:  Exp Suppl       Date:  2021

Review 9.  Beyond binding: antibody effector functions in infectious diseases.

Authors:  Lenette L Lu; Todd J Suscovich; Sarah M Fortune; Galit Alter
Journal:  Nat Rev Immunol       Date:  2017-10-24       Impact factor: 53.106

10.  Protein-Specific Differential Glycosylation of Immunoglobulins in Serum of Ovarian Cancer Patients.

Authors:  L Renee Ruhaak; Kyoungmi Kim; Carol Stroble; Sandra L Taylor; Qiuting Hong; Suzanne Miyamoto; Carlito B Lebrilla; Gary Leiserowitz
Journal:  J Proteome Res       Date:  2016-02-24       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.